Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report

doi:10.1186/1743-422X-6-97

Virology Journal

Volume 6

Viewing options:

Abstract
Full text
PDF (196KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Yang J
Zhao L

on PubMed

Yang J
Zhao L
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Short report

Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report

Jin Yang¹ and Lian-san Zhao²

¹Department of Infectious Diseases, Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen 518052, China

²Center of Infectious Diseases, National Key Laboratory of Biotherapy for Human Diseases, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

author email corresponding author email

Virology Journal 2009, 6:97doi:10.1186/1743-422X-6-97


Published:	8 July 2009

Abstract

We report 4 chinese patients with hepatitis B e antigen-positive chronic hepatitis B achieving clearance of HBsAg by using pegylated interferon alpha-2a for less than 1 year, to provide one clinical clue for the treatment of chronic hepatitis B.